ATLANTA, GA - April 30, 2015 - LED Medical Diagnostics Inc. ("LED Medical" or "the Company") has announced that its subsidiary, LED Dental, has officially launched a new cloud-based imaging solution, LED Imaging Cloud. The system will premiere in booth 2230 at CDA Presents: Anaheim, April 30-May 2 in Anaheim, CA.
LED Imaging Cloud combines the performance of LED Imaging Software with the convenience and security of cloud technology. The web-based system is accessible 24 hours per day, 7 days per week from any location, allowing practitioners real-time, remote access to clinical data for their entire patient database. A solution for both 2D and 3D clinical data, LED Imaging Cloud transcends limitations on CBCT storage found in many current cloud imaging solutions on the market.
Eliminating the need for large onsite imaging servers, LED Imaging Cloud streamlines the process of syncing data between workstations and even multiple locations of large group practices. The ability to serve both small offices and large multi-site practices ensures that LED Imaging Cloud can accommodate even the largest organizational demands. Off-site storage also adds enhanced security with continual back-ups of critical patient records.
"There is a large demand for a cloud-based imaging solution that accommodates both two-dimensional radiographs and 3D CBCT volumes," stated Dr. Jeffrey Brooks, vice president of imaging for LED Dental. "LED Imaging Cloud allows clinicians more convenience, security, and flexibility in how they manage the crucial clinical data for their practice. Combined with powerful imaging tools, LED Imaging Cloud provides a simple path for acquiring, storing, and sharing clinical data, from single-location to multi-office practices."
Finally, the same philosophy of open-architecture that is a hallmark of LED Imaging Software is the foundation of LED Imaging Cloud. Direct integration with any practice management system and most imaging hardware allows practices to combine LED Imaging Cloud with a variety of imaging systems.
"A top priority with LED Imaging Cloud is that the system continues with our philosophy of open-architecture solutions. This system gives doctors a method of integrating all of their imaging hardware, regardless of manufacturer, into one user-friendly, cloud-based platform," stated Lamar Roberts, president of LED Dental. Roberts continued, "We believe that the LED product and service ecosystem has taken a major step forward with the addition of this new unique technology. We are excited about the opportunity to offer a non-hardware based solution that widens the value spectrum at LED. We look forward to introducing this technology to our existing clients as well as to the broader markets. The LED Imaging Cloud creates a parallel customer acquisition funnel that will effectively create cross-ecosystem opportunities with our existing technologies."
For more information on LED Dental and the launch of LED Imaging Cloud, please visit booth 2230 during CDA Presents: Anaheim, April 30-May 2, 2015. You can also find out more at www.leddental.com or call 844.952.7327.
About LED Medical Diagnostics Inc.
Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.
The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.
LED Medical Diagnostics
David Gane, CEO
Phone: 604-434-4614 x227
Forward Looking Statement
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.